Free Trial
→ Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (From Banyan Hill Publishing) (Ad)tc pixel

Olivia Brayer Analyst Performance

Analyst at Cantor Fitzgerald

Olivia Brayer is a stock analyst at Cantor Fitzgerald in the medical sector, covering 6 publicly traded companies. Over the past year, Olivia Brayer has issued 9 stock ratings, including buy and hold recommendations. While full access to Olivia Brayer's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Olivia Brayer's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
9 Last 0 Years
Buy Recommendations
88.89% 8 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy88.9%8 ratings
Hold11.1%1 ratings
Sell0.0%0 ratings

Out of 9 total stock ratings issued by Olivia Brayer at Cantor Fitzgerald, the majority (88.9%) have been Buy recommendations, followed by 11.1% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
83.3% of companies on NASDAQ
5 companies
NYSE
16.7% of companies on NYSE
1 company

Olivia Brayer, an analyst at Cantor Fitzgerald, currently covers 6 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
6 companies		100.0%

Olivia Brayer of Cantor Fitzgerald specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
5 companies		83.3%
MED - DRUGS
1 company		16.7%

Olivia Brayer's Ratings History at Cantor Fitzgerald

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export to Excel
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
9/11/2025Reiterated Rating$3.11Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
9/10/2025Boost Price Target$403.80$525.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
6/2/2025Initiated Coverage$316.34$405.00Overweight
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
5/14/2025Reiterated Rating$3.92$13.00Overweight
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/20/2025Reiterated Rating$68.49$90.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Reiterated Rating$460.76$480.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2/4/2025Boost Price Target$60.03$55.00Neutral
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/31/2025Reiterated Rating$462.91$480.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/24/2025Reiterated Rating$439.97$480.00Overweight
Today's Ratings
Top-Rated Stocks
More Ratings Tools